Gene Delivery Systems Market
Gene Delivery Systems Market By Delivery (Viral Gene Delivery, Non-viral Gene Delivery), By Route of Administration (Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal), By Application (Infectious Diseases, Oncology, CVD, Urology, CNS) & Region - Global Market Insights 2022 to 2027
Analysis of Gene Delivery Systems market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Gene Delivery Systems Market Outlook (2022-2027)
The global gene delivery systems market currently accounts for a valuation of US$ 3 billion and is expected to reach US$ 4.1 billion by the end of 2027. Global demand for gene delivery systems is predicted to magnify at a CAGR of 6.5% from 2022 to 2027.
Demand for viral gene delivery systems is anticipated to rise rapidly at a CAGR of 7% through 2027. Viral gene delivery systems are used for treating genetic illnesses caused by the insertion or deletion of a gene.
Report Attributes |
Details |
|---|---|
|
Gene Delivery Systems Market Size (2022) |
US$ 3 Billion |
|
Projected Market Value (2027) |
US$ 4.1 Billion |
|
Global Market Growth Rate (2022-2027) |
6.5% CAGR |
|
Market Share of Viral Gene Delivery |
85% |
|
Share in Gene Therapy Market (2022) |
30% |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis of Gene Delivery Systems (2017-2021) Vs Market Projections (2022-2027)
“Rising Prevalence of Chronic Diseases Driving Demand for Gene Delivery Systems”
According to Fact.MR, a market research and competitive intelligence provider, the gene delivery systems market is projected to increase at a CAGR of 6.5% from 2022 to 2027.
Gene delivery systems can significantly improve the human therapies used to cure disease. A process called gene delivery inserts foreign DNA into host cells. Growing adoption of targeted therapies and innovations in gene delivery systems are expected to drive market expansion over the coming years.
Market growth is primarily driven by the rising prevalence of chronic diseases and the growing demand for targeted medicines. Market expansion has been fueled by the expanding ongoing research and development in the field of genetics at a global level, increasing need for genetic disorder therapeutics, and rising demand for self-administration tools for home-based health care.
Other factors that are anticipated to contribute to market expansion include the rising demand for targeted and low-dose frequency drug delivery, the increasing need for advanced technologies for targeted systems, and the introduction of new and superior methods such as adenovirus vectors, lentivirus vectors, and retrovirus vectors.
All of these important variables are anticipated to fuel market expansion for gene delivery systems over the coming years.
What Aspects Drive Gene Delivery Systems Market Growth?
“Development of Cell & Gene Therapies Supporting Market Expansion”
The development of cell and gene therapies has significantly altered not just how genetic and incurable diseases are treated, but also how the entire pharmaceutical industry is structured. One of the main factors influencing the market for gene delivery methods is the rapidly changing landscape of innovative medicines.
The global market for gene delivery systems is expanding due to the increased prevalence of different chronic diseases such as cancer, diabetes, cardiovascular diseases, and other chronic diseases as well as technological advancements in drug administration.
The demand for gene delivery solutions has increased as a result of patients' and physicians' changing preferences. The development of the global market for gene delivery systems has been considerably aided by the advent of auto-injectors, genealogy products & services, biopharmaceutical classification techniques, implants with configurable shapes and sizes, and adaptive aerosol delivery systems.
The demand for gene delivery systems has increased due to the increasing use of gene treatments and novel drugs as a result of growing public awareness about the existence of new medications that can successfully treat chronic conditions. One of the key factors propelling the market is the increase in funding for the discovery of new pharmaceuticals and therapies for the treatment of incurable diseases.
“Introduction of Several Revolutionary Tools for Genetic Modifications”
The activation of physical gene delivery techniques such as megnetoporation, optoporation, sonoporation, and electroporation has been made possible by emerging nanotechnology and physical technology. More people are paying attention to this technological breakthrough because of its better functionality and nontoxicity. These factors have also increased the use of gene delivery systems.
Some of the main driving factors are technological advancements in viral vectors, an expanding pipeline of advanced therapies, and an increase in the number of regulatory approvals for innovative therapy products.
The development of new gene delivery techniques has been aided by the introduction of several revolutionary tools for genetic modifications that have made it easier for the scientific community to outline the complexities of disease at the genomic level.
The market revenue is also being boosted by continuous research to create clinically useful vectors, including adeno-associated virus vectors, sendai virus vectors, and herpes simplex virus vectors to treat chronic diseases such as cancer, Alzheimer's, and others with innovative medicines.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is Market Expansion Being Restrained to Some Extent?
“High Treatment Costs and Efficacy & Safety Concerns”
The market is anticipated to be constrained by high treatment costs, efficacy and safety concerns, long clinical study procedures, stringent regulations for product approvals, and an increase in drug recalls.
How are Start-ups Sculpting Their Progress in the Gene Delivery Systems Market?
“Aspiring Market Players Focused on Innovations in Non-viral Gene Therapies”
It is projected that the growing public and private interest in gene delivery technologies would hasten the entry of new firms into the market. New companies are investing in R&D to create high-end gene delivery systems and address problems, worries, and adverse effects associated with their use.
Viral vectors are limited by the size of the virus chassis, which makes it difficult to transmit significant genetic payloads. Additionally, some people may develop cancer or experience inflammatory reactions as a result of viral gene therapy. These issues are resolved by non-viral gene therapies, which successfully expand the patient population who can benefit from gene therapy.
- Generation Bio, a start-up based in the U.S., provides non-viral gene treatment options. Their technology, which uses a unique closed-ended deoxyribonucleic acid (ceDNA) system, may deliver one or multiple genes to a cell. It also can provide long-lasting gene expression by allowing higher loads.
Which Region Spearheads Gene Delivery System Demand?
“Higher Consumer Awareness of Improved Drug Delivery Systems North America”
North America leads the gene delivery systems market. The market is expanding as a result of rising demand for biological gene delivery systems, rising adoption of innovative products, and rising consumer awareness of improved drug delivery systems.
Increased prevalence of chronic diseases, technological advancements in genetic analyzer systems, and the presence of key players are driving market growth in the region.
Increasing rates of hospitalizations, technological advancements in drug delivery systems, and rising research and innovation initiatives for the development of gene delivery systems are driving market expansion in the region.
Country-wise Insights
Why is the Market for Gene Delivery Systems Prominent in the U.S?
“Growing Public & Private Investments in Development of Advanced Gene Therapy Products”
According to research, approximately 60% of the U.S. population has at least one chronic illness. The U.S. market is growing as a result of rising viral gene delivery system usage, growing public and private investments in the development of advanced gene therapy products, and a well-established biotechnology industry.
The growing awareness among the population of advanced technology for the treatment of hereditary and rising involvement by key businesses in the production and marketing of gene delivery technologies are the factors driving market expansion.
Why are Suppliers of Gene Delivery Systems Attracted to China?
“Rapid Expansion of Pharmaceutical Industry in China”
The gene delivery systems market in China is expected to rise at a CAGR of 6% over the forecast period.
China is recognised as a gene therapy hub. Market expansion is attributed to the growing acceptance of personalized medications, the rapid expansion of the pharmaceutical industry, the presence of a large population, and the rising incidence of diseases brought on by pollution as a result of rapid industrialization and urbanization.
Due to a huge patient base and the increase of production capacity by major players to meet the rising demand for gene delivery systems, the market in China is anticipated to grow quickly.
Category-wise Insights
Why are Viral Gene Delivery Systems Mostly Preferred?
“Strong Emphasis by Governments on Public Education about Viral Gene Delivery Systems”
Based on the delivery, the gene delivery systems market is divided into viral gene delivery and non-viral gene delivery. Viral gene delivery systems account for 85% share of the global market.
Due to characteristics such as long-term expression, short-term expression, and therapeutic gene efficacy as well as recent technological advancements that have created numerous growth opportunities in the healthcare sector, it is anticipated that viral gene delivery systems will continue to hold a dominant market share. Market growth of gene delivery systems has also been aided by the rising prevalence of cardiovascular ailments.
These gene delivery technologies have gained widespread acceptance as a result of governments placing a greater emphasis on public education regarding these treatments.
Which Application Accounts for the Highest Sales of Gene Delivery Systems?
“Growing Prevalence of Cancer Driving High Demand for Gene Delivery Systems in Oncology”
The gene delivery systems market is segmented into infectious diseases, oncology, CVD, urology, CNS, and others based on the application. The global gene delivery systems market is dominated by the oncology segment in terms of revenue. Global demand for gene delivery devices is being driven by an increase in cancer incidence in all regions.
The demand for innovative drug delivery systems in the oncology segment has increased due to the rising incidence of malignancies such as leukemia, brain tumors, colon cancer, stomach cancer, and others.
Growing prevalence of cancer disorders, the increased emphasis on research to create a successful cancer treatment, and rising funding in cancer research are the key drivers of segment growth.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Market expansion is being fueled by strategic agreements formed by companies developing cell and gene therapies with vector suppliers. Due to the presence of numerous domestic and international producers of gene delivery systems, the global market for gene delivery systems is very competitive.
For instance :
- Nanoparticles demonstrated their effectiveness as prospective carriers for clinical utilization due to their customizable shape and biological activities.
- Brammer Bio, a company that produces viral vectors for gene therapies, was acquired by Thermo Fisher Scientific.
Segments of Gene Delivery Systems Industry Research
-
By Delivery :
- Viral Gene Delivery
- Non-viral Gene Delivery
-
By Route of Administration :
- Oral
- Injectable
- Inhalation
- Transdermal
- Ocular
- Nasal
- Others
-
By Application :
- Infectious Diseases
- Oncology
- CVD
- Urology
- CNS
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Global Gene Delivery Systems Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Gene Delivery Systems Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Gene Delivery Systems 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Gene Delivery Systems Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2020 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Source Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Gene Delivery Systems – Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Gene Delivery Systems 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Gene Delivery Systems Market Demand (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2027 5.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027, By Delivery 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Delivery, 2017-2021 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Delivery, 2022-2027 6.3.1. Viral Gene Delivery 6.3.2. Non-viral Gene Delivery 6.4. Market Attractiveness Analysis By Delivery 7. Global Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027, by Route of Administration 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Route of Administration , 2017-2021 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2027 7.3.1. Oral 7.3.2. Injectable 7.3.3. Inhalation 7.3.4. Transdermal 7.3.5. Ocular 7.3.6. Nasal 7.3.7. Others 7.4. Market Attractiveness Analysis By Route of Administration 8. Global Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027, by Application 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By Application, 2017-2021 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2022-2027 8.3.1. Infectious Diseases 8.3.2. Oncology 8.3.3. CVD 8.3.4. Urology 8.3.5. CNS 8.3.6. Others 8.4. Market Attractiveness Analysis By Application 9. Global Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2027 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Delivery 10.3.3. By Route of Administration 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Delivery 10.4.3. By Route of Administration 11. Latin America Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Delivery 11.3.3. By Route of Administration 11.3.4. By Application 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Delivery 11.4.3. By Route of Administration 11.4.4. By Application 12. Europe Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. UK 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Delivery 12.3.3. By Route of Administration 12.3.4. By Application 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Delivery 12.4.3. By Route of Administration 12.4.4. By Application 13. East Asia Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Delivery 13.3.3. By Route of Administration 13.3.4. By Application 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Delivery 13.4.3. By Route of Administration 13.4.4. By Application 14. South Asia & Oceania Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Delivery 14.3.3. By Route of Administration 14.3.4. By Application 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Delivery 14.4.3. By Route of Administration 14.4.4. By Application 15. Middle East and Africa Gene Delivery Systems Market Analysis 2017-2021 and Forecast 2022-2027 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Delivery 15.3.3. By Route of Administration 15.3.4. By Application 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Delivery 15.4.3. By Route of Administration 15.4.4. By Application 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Amgen, Inc. 17.3.1.1. Company Overview 17.3.1.2. Source overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Bayer AG 17.3.2.1. Company Overview 17.3.2.2. Source overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Pfizer, Inc. 17.3.3.1. Company Overview 17.3.3.2. Source overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Novartis AG 17.3.4.1. Company Overview 17.3.4.2. Source overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Johnson & Johnson 17.3.5.1. Company Overview 17.3.5.2. Source overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Human Stem Cells Institute 17.3.6.1. Company Overview 17.3.6.2. Source overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Oxford Biomedica plc 17.3.7.1. Company Overview 17.3.7.2. Source overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Shanghai Sunway Biotech Co., Ltd. 17.3.8.1. Company Overview 17.3.8.2. Source overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Sibiono GeneTech Co. Ltd. 17.3.9.1. Company Overview 17.3.9.2. Source overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017-2021
Table 02: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022-2027
Table 03: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022-2027
Table 04: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017-2021
Table 05: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022-2027
Table 06: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022-2027
Table 07: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 08: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 09: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 10: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Region, 2017-2021
Table 11: Global Gene Delivery Systems Market Value (US$ Mn) Analysis, by Region, 2022-2027
Table 12: Global Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Region, 2022-2027
Table 13: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 14: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 15: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 16: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017-2021
Table 17: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022-2027
Table 18: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022-2027
Table 19: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017-2021
Table 20: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022-2027
Table 21: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022-2027
Table 22: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 23: North America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 24: North America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 25: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 26: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 27: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 28: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017-2021
Table 29: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022-2027
Table 30: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022-2027
Table 31: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017-2021
Table 32: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022-2027
Table 33: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022-2027
Table 34: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 35: Latin America Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 36: Latin America Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 37: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 38: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 39: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 40: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017-2021
Table 41: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022-2027
Table 42: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022-2027
Table 43: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017-2021
Table 44: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022-2027
Table 45: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022-2027
Table 46: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 47: Europe Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 48: Europe Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 49: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 50: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 51: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 52: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017-2021
Table 53: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022-2027
Table 54: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022-2027
Table 55: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017-2021
Table 56: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022-2027
Table 57: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022-2027
Table 58: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 59: East Asia Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 60: East Asia Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 61: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 62: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 63: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 64: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017-2021
Table 65: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022-2027
Table 66: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022-2027
Table 67: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017-2021
Table 68: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022-2027
Table 69: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022-2027
Table 70: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 71: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 72: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 73: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 74: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 75: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 76: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2017-2021
Table 77: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Delivery, 2022-2027
Table 78: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Delivery, 2022-2027
Table 79: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2017-2021
Table 80: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Route of Administration, 2022-2027
Table 81: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2022-2027
Table 82: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 83: MEA Gene Delivery Systems Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 84: MEA Gene Delivery Systems Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Gene Delivery Systems Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 02: Global Gene Delivery Systems Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 03: Global Gene Delivery Systems Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 04: Global Gene Delivery Systems Market Incremental $ Opportunity, 2022-2027
Figure 05: Global Gene Delivery Systems Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 06: Global Gene Delivery Systems Market Y-o-Y Growth Projections by Delivery, 2022-2027
Figure 07: Global Gene Delivery Systems Market Attractiveness Analysis by Delivery, 2022-2027
Figure 08: Global Gene Delivery Systems Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 09: Global Gene Delivery Systems Market Y-o-Y Growth Projections by Route of Administration, 2022-2027
Figure 10: Global Gene Delivery Systems Market Attractiveness Analysis by Route of Administration, 2022-2027
Figure 11: Global Gene Delivery Systems Market Share and BPS Analysis by Application, 2022 & 2027
Figure 12: Global Gene Delivery Systems Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 13: Global Gene Delivery Systems Market Attractiveness Analysis by Application, 2022-2027
Figure 14: Global Gene Delivery Systems Market Share and BPS Analysis by Region, 2022 & 2027
Figure 15: Global Gene Delivery Systems Market Y-o-Y Growth Projections by Region, 2022-2027
Figure 16: Global Gene Delivery Systems Market Attractiveness Analysis by Region, 2022-2027
Figure 17: North America Gene Delivery Systems Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 18: North America Gene Delivery Systems Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 19: North America Gene Delivery Systems Market Value Y-o-Y Growth and Forecast, 2022-2027
Figure 20: North America Gene Delivery Systems Market Incremental $ Opportunity, 2022-2027
Figure 21: North America Gene Delivery Systems Market Share Analysis by Country, 2022 & 2027
Figure 22: North America Gene Delivery Systems Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 23: North America Gene Delivery Systems Market Attractiveness Analysis by Country, 2022-2027
Figure 24: North America Gene Delivery Systems Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 25: North America Gene Delivery Systems Market Y-o-Y Growth Projections by Delivery, 2022-2027
Figure 26: North America Gene Delivery Systems Market Attractiveness Analysis by Delivery, 2022-2027
Figure 27: North America Gene Delivery Systems Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 28: North America Gene Delivery Systems Market Y-o-Y Growth Projections by Route of Administration, 2022-2027
Figure 29: North America Gene Delivery Systems Market Attractiveness Analysis by Route of Administration, 2022-2027
Figure 30: North America Gene Delivery Systems Market Share and BPS Analysis by Application, 2022 & 2027
Figure 31: North America Gene Delivery Systems Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 32: North America Gene Delivery Systems Market Attractiveness Analysis by Application, 2022-2027
Figure 33: Latin America Gene Delivery Systems Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 34: Latin America Gene Delivery Systems Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 35: Latin America Gene Delivery Systems Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 36: Latin America Gene Delivery Systems Market Incremental $ Opportunity, 2022-2027
Figure 37: Latin America Gene Delivery Systems Market Share Analysis by Country, 2022 & 2027
Figure 38: Latin America Gene Delivery Systems Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 39: Latin America Gene Delivery Systems Market Attractiveness Analysis by Country, 2022-2027
Figure 40: Latin America Gene Delivery Systems Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 41: Latin America Gene Delivery Systems Market Y-o-Y Growth Projections by Delivery, 2022-2027
Figure 42: Latin America Gene Delivery Systems Market Attractiveness Analysis by Delivery, 2022-2027
Figure 43: Latin America Gene Delivery Systems Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 44: Latin America Gene Delivery Systems Market Y-o-Y Growth Projections by Route of Administration, 2022-2027
Figure 45: Latin America Gene Delivery Systems Market Attractiveness Analysis by Route of Administration, 2022-2027
Figure 46: Latin America Gene Delivery Systems Market Share and BPS Analysis by Application, 2022 & 2027
Figure 47: Latin America Gene Delivery Systems Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 48: Latin America Gene Delivery Systems Market Attractiveness Analysis by Application, 2022-2027
Figure 49: Europe Gene Delivery Systems Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 50: Europe Gene Delivery Systems Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 51: Europe Gene Delivery Systems Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 52: Europe Gene Delivery Systems Market Incremental $ Opportunity, 2022-2027
Figure 53: Europe Gene Delivery Systems Market Share Analysis by Country, 2022 & 2027
Figure 54: Europe Gene Delivery Systems Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 55: Europe Gene Delivery Systems Market Attractiveness Analysis by Country, 2022-2027
Figure 56: Europe Gene Delivery Systems Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 57: Europe Gene Delivery Systems Market Y-o-Y Growth Projections by Delivery, 2022-2027
Figure 58: Europe Gene Delivery Systems Market Attractiveness Analysis by Delivery, 2022-2027
Figure 59: Europe Gene Delivery Systems Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 60: Europe Gene Delivery Systems Market Y-o-Y Growth Projections by Route of Administration, 2022-2027
Figure 61: Europe Gene Delivery Systems Market Attractiveness Analysis by Route of Administration, 2022-2027
Figure 62: Europe Gene Delivery Systems Market Share and BPS Analysis by Application, 2022 & 2027
Figure 63: Europe Gene Delivery Systems Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 64: Europe Gene Delivery Systems Market Attractiveness Analysis by Application, 2022-2027
Figure 65: East Asia Gene Delivery Systems Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 66: East Asia Gene Delivery Systems Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 67: East Asia Gene Delivery Systems Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 68: East Asia Gene Delivery Systems Market Incremental $ Opportunity, 2022-2027
Figure 69: East Asia Gene Delivery Systems Market Share Analysis by Country, 2022 & 2027
Figure 70: East Asia Gene Delivery Systems Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 71: East Asia Gene Delivery Systems Market Attractiveness Analysis by Country, 2022-2027
Figure 72: East Asia Gene Delivery Systems Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 73: East Asia Gene Delivery Systems Market Y-o-Y Growth Projections by Delivery, 2022-2027
Figure 74: East Asia Gene Delivery Systems Market Attractiveness Analysis by Delivery, 2022-2027
Figure 75: East Asia Gene Delivery Systems Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 76: East Asia Gene Delivery Systems Market Y-o-Y Growth Projections by Route of Administration, 2022-2027
Figure 77: East Asia Gene Delivery Systems Market Attractiveness Analysis by Route of Administration, 2022-2027
Figure 78: East Asia Gene Delivery Systems Market Share and BPS Analysis by Application, 2022 & 2027
Figure 79: East Asia Gene Delivery Systems Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 80: East Asia Gene Delivery Systems Market Attractiveness Analysis by Application, 2022-2027
Figure 81: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 82: South Asia & Oceania Gene Delivery Systems Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 83: South Asia & Oceania Gene Delivery Systems Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 84: South Asia & Oceania Gene Delivery Systems Market Incremental $ Opportunity, 2022-2027
Figure 85: South Asia & Oceania Gene Delivery Systems Market Share Analysis by Country, 2022 & 2027
Figure 86: South Asia & Oceania Gene Delivery Systems Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 87: South Asia & Oceania Gene Delivery Systems Market Attractiveness Analysis by Country, 2022-2027
Figure 88: South Asia & Oceania Gene Delivery Systems Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 89: South Asia & Oceania Gene Delivery Systems Market Y-o-Y Growth Projections by Delivery, 2022-2027
Figure 90: South Asia & Oceania Gene Delivery Systems Market Attractiveness Analysis by Delivery, 2022-2027
Figure 91: South Asia & Oceania Gene Delivery Systems Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 92: South Asia & Oceania Gene Delivery Systems Market Y-o-Y Growth Projections by Route of Administration, 2022-2027
Figure 93: South Asia & Oceania Gene Delivery Systems Market Attractiveness Analysis by Route of Administration, 2022-2027
Figure 94: South Asia & Oceania Gene Delivery Systems Market Share and BPS Analysis by Application, 2022 & 2027
Figure 95: South Asia & Oceania Gene Delivery Systems Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 96: South Asia & Oceania Gene Delivery Systems Market Attractiveness Analysis by Application, 2022-2027
Figure 97: MEA Gene Delivery Systems Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 98: MEA Gene Delivery Systems Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 99: MEA Gene Delivery Systems Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 100: MEA Gene Delivery Systems Market Incremental $ Opportunity, 2022-2027
Figure 101: MEA Gene Delivery Systems Market Share Analysis by Country, 2022 & 2027
Figure 102: MEA Gene Delivery Systems Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 103: MEA Gene Delivery Systems Market Attractiveness Analysis by Country, 2022-2027
Figure 104: MEA Gene Delivery Systems Market Share and BPS Analysis by Delivery, 2022 & 2027
Figure 105: MEA Gene Delivery Systems Market Y-o-Y Growth Projections by Delivery, 2022-2027
Figure 106: MEA Gene Delivery Systems Market Attractiveness Analysis by Delivery, 2022-2027
Figure 107: MEA Gene Delivery Systems Market Share and BPS Analysis by Route of Administration, 2022 & 2027
Figure 108: MEA Gene Delivery Systems Market Y-o-Y Growth Projections by Route of Administration, 2022-2027
Figure 109: MEA Gene Delivery Systems Market Attractiveness Analysis by Route of Administration, 2022-2027
Figure 110: MEA Gene Delivery Systems Market Share and BPS Analysis by Application, 2022 & 2027
Figure 111: MEA Gene Delivery Systems Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 112: MEA Gene Delivery Systems Market Attractiveness Analysis by Application, 2022-2027
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the estimated value of the global gene delivery systems market?
The global market for gene delivery systems is estimated to reach US$ 4.1 billion by 2027.
How big is the gene delivery systems market?
The global gene delivery systems market is valued at US$ 3 billion.
What are the factors driving the growth of the gene delivery systems market?
Growing burden of chronic diseases & lifestyle disorders and technological advancements in research by biopharmaceutical companies are factors driving market growth.
What is the predicted growth rate of the gene delivery devices market?
The global gene delivery systems market is predicted to increase at 6.5% CAGR from 2022 to 2027.
Who are the key players in the gene delivery systems market?
Amgen, Inc., Bayer AG, and Pfizer, Inc. are key manufacturers of gene delivery systems.
Gene Delivery Systems Market